MDxHealth (MDXH) EBITDA Margin (2022 - 2026)
MDxHealth (MDXH) posted EBITDA Margin of 15.84% for Q1 2026, down 121.64% sequentially from 7.15% in Q4 2025, and down 1036.0% YoY from 1.69% in Q1 2025.
MDxHealth (MDXH) EBITDA Margin (2022 - 2026) Analysis & Trends
MDxHealth has reported EBITDA Margin for 5 years, with the latest figure at 15.84% in Q1 2026.
- Quarterly EBITDA Margin fell 1036.0% year-over-year to 15.84% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 2.21% (up 992.0% YoY) and the FY2025 annual result came in at 1.05%, up 1524.0% from the prior year.
- EBITDA Margin slipped to 15.84% in Q1 2026 per MDXH's latest filing, from 7.15% in the prior quarter.
- Over five years, EBITDA Margin peaked at 2.67% in Q2 2025 and troughed at 106.96% in Q3 2022.
- A 5-year average of 31.95% and a median of 22.06% in 2024 frame the typical range for EBITDA Margin.
- The sharpest annual moves came in 2024 and 2026: EBITDA Margin surged 8384 bps in 2024, then sank 1036 bps in 2026.
- Over 5 years, EBITDA Margin stood at 69.41% in 2022, then jumped by 68 bps to 22.53% in 2023, then jumped by 75 bps to 5.57% in 2024, then slipped by 28 bps to 7.15% in 2025, then tumbled by 122 bps to 15.84% in 2026.
- According to Business Quant data, EBITDA Margin over the past three periods registered 15.84%, 7.15%, and 1.25% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 17.40% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 17.99% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 34.98% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 21.74% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 11.58% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -13.42% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 21.14% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 31.97% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 15.08% |
| 10 | MDxHealth | 21.81 Mn | -21.34 Mn | 16.61 Mn | -15.84% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.84% |
| Dec 31, 2025 | -7.15% |
| Sep 30, 2025 | 1.25% |
| Jun 30, 2025 | 2.67% |
| Mar 31, 2025 | -5.48% |
| Dec 31, 2024 | -5.57% |
| Sep 30, 2024 | -16.59% |
| Jun 30, 2024 | -22.06% |
| Mar 31, 2024 | -22.87% |
| Dec 31, 2023 | -22.53% |
| Sep 30, 2023 | -23.57% |
| Jun 30, 2023 | -105.90% |
| Mar 31, 2023 | -59.30% |
| Dec 31, 2022 | -69.41% |
| Sep 30, 2022 | -106.96% |